Gambo Aliyu

Datos Biográficos

ID8929744
NOMBREGambo Aliyu
NOMBRESGambo
APELLIDOAliyu
FIRMAALIYU G
AFILIACIONESNational Agency for the Control of AIDS
ORCID0000-0002-9661-3463
VERIFICADOSí
TOTAL DE OBRAS7
TOTAL DE CITAS0
TOTAL COMO AUTOR7
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2010
AÑO MÁS RECIENTE DE PUBLICACIÓN2024
ÍNDICE H0

  • HIV risk behaviour, viraemia, and transmission across HIV cascade stages including low-level viremia

    Open AccessOlanrewaju Edun, Lucy Okell et al.ARTICLEPLOS Global Public Health2024

    As antiretroviral treatment (ART) coverage for people living with HIV (PLHIV) increases, HIV programmes require up-to-date information about evolving HIV risk behaviour and transmission risk, including those with low-level viremia (LLV; >50 to ≤1000 copies/mL), to guide prevention priorities. We aimed to assess differences in sexual risk behaviours, distribution of viral load (VL) and proportion of transmission across PLHIV subgroups. We analysed…

  • Mpox (monkeypox) risk and mortality associated with HIV infection

    Open AccessAdesola Yinka-Ogunleye, Mahmood Dalhat et al.ARTICLEBMJ Global Health2023

    INTRODUCTION: Recent outbreaks of mpox are characterised by changes in the natural history of the disease, the demographic and clinical characteristics of the cases, and widening geographical distribution. We investigated the role of HIV and other sexually transmitted infections (STIs) coinfection among cases in the re-emergence of mpox to inform national and global response. METHODS: We conducted a national descriptive and case-control study on …

  • An analysis of the uptake of anti-retroviral treatment among pregnant women in Nigeria from 2015 to 2020

    Open AccessAkudo Ikpeazu, Samuel Anya et al.ARTICLEPLOS Global Public Health2023

    The percentage of Human Immunodeficiency Virus (HIV) positive pregnant women that receive anti-retroviral treatment in Nigeria is low and has been declining. Consequently, 14% of all new infections among children in 2020 occurred in Nigeria. A detailed analysis of available data was undertaken to generate evidence to inform remedial actions. Data from routine service delivery, national surveys and models were analyzed for the six-year period from…

  • The Lancet Nigeria Commission

    Open AccessIbrahim Abubakar, Sarah L Dalglish et al.ARTICLEThe Lancet2022

    Health is central to the development of any country. Nigeria’s gross domestic product is the largest in Africa, but its per capita income of about ₦770 000 (US$2000) is low with a highly inequitable distribution of income, wealth, and therefore, health. It is a picture of poverty amidst plenty. Nigeria is both a wealthy country and a very poor one. About 40% of Nigerians live in poverty, in social conditions that create ill health, and with the e…

  • Building a national framework for multicentre research and clinical trials

    Open AccessJohn O Olawepo, Echezona E Ezeanolue et al.ARTICLEBMJ Global Health2022

    There is limited capacity and infrastructure in sub-Saharan Africa to conduct clinical trials for the identification of efficient and effective new prevention, diagnostic and treatment modalities to address the disproportionate burden of disease. This paper reports on the process to establish locally driven infrastructure for multicentre research and trials in Nigeria known as the Nigeria Implementation Science Alliance Model Innovation and Resea…

  • HIV counseling and testing and access-to-care needs of populations most-at-risk for HIV in Nigeria

    Ahmed Saidu, Saidu Ahmed et al.ARTICLEAIDS Care2013

    Mobile HIV counseling and testing (mHCT) is an effective tool to access hard-to-reach most-at-risk populations (MARPs), but identifying which populations are not accessing services is often a challenge. We compared correlates of human immunodeficiency virus (HIV) infection and awareness of HIV care services among populations tested through mHCT and at testing facilities in Nigeria. Participants in a cross-sectional study completed a questionnaire…

  • HIV infection awareness and willingness to participate in future HIV vaccine trials across different risk groups in Abuja, Nigeria

    Gambo Aliyu, Mukhtar Mohammad et al.ARTICLEAIDS Care2010

    The purpose of this survey is to generate baseline data on the level of HIV infection awareness and willingness to participate (WTP) in hypothetical vaccine trials, ahead of any trial conduct in Nigeria. In a cross-sectional survey, 500 respondents were interviewed, including sex workers, male motorcycle taxi drivers, students, and the general public. About 153 (30.6%) of the respondents did not believe that correct and consistent use of condom c…